Hantavirus vaccine in 2026?
Probability
9¢
1h
+0.0pp
24h
+1.0pp
24h Vol
$12.3K
Liquidity
$140.4K
Resolution & Risk
LOW risk- End date
- Dec 31, 2026
- UMA status
- n/a
- Resolution source
- Market type
- Binary
- No obvious resolution-risk signals in metadata.
Probability (last 7 days)
+0.0pp 7dWhy did it move?
Structured · 2 factors- 01Price move
Up 1pp over 24h
Now 9¢; flat in the last hour.
- 02Volume pressure
Light volume — move on a thin book
Only $12.3k traded against $140.4k of visible liquidity (0.09× turnover). Treat the move as low-confidence until volume confirms.
What to track next
- Set an alert at the next ±5pp probability move so you find out before the next leg.
- Add to your watchlist — Home will show probability deltas since your last visit.
- Compare against sibling markets in the same event below — divergent pricing across related contracts is the cleanest tell.
Verification actions only — never trade recommendations.
Each factor is grounded in a single named metric you can verify on this page — probability, volume, liquidity, signal, resolution state. No predictions, no prose hallucinations.
Resolution & Risk
LOW risk- End date
- Dec 31, 2026
- UMA status
- n/a
- Resolution source
- Market type
- Binary
- No obvious resolution-risk signals in metadata.
Timeline
critical · price · trade flowCritical
- 0s agoResolveLOW
Market resolves in 5730.8h
Price movement
+1.0pp over the last 24h, now 9¢.
Recent Trades
No recent trades visible from the Data API for this market. That usually means liquidity is thin or this market is between event windows.
Market Description
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Alerts
In-app banners fire as soon as a rule is satisfied. Email, Telegram, and Discord delivery are coming soon — every existing rule will keep working without changes.
